Summary
The results of experiments in dogs with and without two glucose loads and in the isolated pancreas to compare the pharmacodynamics of two low-dosage aryl-sulphonylureas, glipizide and glibenclamide, are described and discussed. — The results agree with those obtained by other authors confirming that glibenclamide shows delayed but prolonged activity on both plasma insulin and glucose levels. Moreover glibenclamide counteracts the hyperglycaemia induced by the second glucose load less efficently. Glipizide acts faster on insulin and glucose levels, which return quickly to normal. When a second glucose load was given it was still more active in reducing plasma glucose levels. The dynamics of insulin secretion following glipizide more closely resembles tolbutamide than glibenclamide.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Parenti, M. A., Rabini, T., Tommasini, R.: New oral antidiabetic drugs. Part I. Arzneimittel-Forsch.21, 200–204 (1971)
Ambrogi, V., Bloch, K., Cozzi, P., Daturi, S., Logemann, W., Parenti, M.A., Tommasini, R.: New oral antidiabetic drugs. Part II. Arzneimittel-Forsch.21, 204–208 (1971)
Ambrogi, V., Bloch, K., Daturi, S., Logemann, W. Parenti, M.A., Tommasini, R.: New oral antidiabetic drugs. Part III. Arzneimittel-Forsch.22, 542–544 (1972)
Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Mandelli, V., Parenti, M.A., Rabini, T., Usardi, M.M., Tommasini, R.: Pharmacological study on a new oral antidiabetic: N-{4-[β-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzenesulphonyl}-N′-cyclohexyl-urea or K 4024. Arzneimittel-Forsch.21, 208–215 (1971)
Fuccella, L.M., Tamassia, V., Valzelli, G.: Metabolism and kinetics of the hypoglycaemic agent glipizide in man. Comparison with glibenclamide. Clin. Pharm. and New Drugs. (In press)
Valzelli, G., Tamassia, V.: Personal communication
Frings, C.S., Ratliff, C.R., Dunn, R.T.: Automated determination of glucose in serum or plasma by direct o-toluidine procedure. Clin. Chem.16, 282–284 (1970)
Hales, C.N., Randle, P.J.: Immuno-assay of insulin with insulin-antibody precipitate. Biochem. J.88, 137–146 (1963)
Kramer, C.Y.: Extention of multiple range test to group means with unequal number of replications. Biometrics12, 307–310 (1956)
Loubatières, A., Mariani, M.A., Ribes, G., de Malbosc, H., Chapal, J.: Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia5, 1–10 (1969)
Wilcoxon, F.: Individual comparison by ranking methods. Biomet. Bull.1, 80–83 (1945)
Loubatières A., Mariani, M.M.: Etude pharmacologique et pharmacodynamique d'un sulfonylurée hypoglycémiant particulièrement actif, le glybenzcyclamide. C.R. Acad. Sci. (Paris)265, 643–645 (1967)
Loubatières, A.: Stimulators and inhibitors of insulin secretion. Physiological and pharmacological interferences synergisms and antagonisms. In: Mechanism and regulation of insulin secretion, p. 243–244. Levine, R., Pfeiffer, E.F. (Eds.). Milano: Casa Editrice “Il Ponte”, 1968
Raptis, S., Rav, R.M., Schröder, K.E., Faulchaber, D.J., Pfeiffer, E.F.: Comparative study of insulin secretion following repeated administration of glucose, tolbutamide and glibenclamide (HB 419) in diabetic and non-diabetic human subjects. Horm. Metab. Res. 1 suppl., 65–72 (1969)
Haupt, E., Köberich, W., Beyer, J., Schöffling, K.: Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I) Dose response relations and repeated administration in diabetic subjects. II) Repeated administration in combination with glucose. Diabetologia7, 449–460 (1971)
Fussgänger, R.D., Goberna, R., Hinz, M., Jaros, P., Karsten, C., Pfeiffer, E.F.: Comparative studies on the dynamics of insulin secretion following HB 419 and tolbutamide on the perfused isolated rat pancreas on the perifused isolated islets of Langerhans. Horm. Metab. Res. 1 suppl. 34–40 (1969)
Grodsky, G.M., Lee, J., Fanska, R., Smith, D.: Insulin secretion from the “in vitro” perfused pancreas of the rat. Effect of RO 6-4563 and other sulfonylureas. Recent Hypoglycemic Sulfonylureas, pp. 83–96. Bern: Hans Huber 1971
Pfeiffer, E.F., Fussgänger, R., Hinz, H., Kastilambros, N., Laube, H.: Dynamics of insulin and glucagon secretion of the isolated perfused pancreas and islets following and in presence of newer sulfonylureas. Recent Hypoglycemic Sulfonylureas. Bern: Hans Huber 97–112 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Artini, D., Abbiati, R., Orsini, G. et al. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. Diabetologia 9 (Suppl 1), 311–316 (1973). https://doi.org/10.1007/BF01218440
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01218440